Takuya Tada

16PUBLICATIONS
34CO-AUTHORS
Medical molecular engineering of nucleic acids and proteinsMedical infection agents (incl. prions)Molecular targetsGene and molecular therapyChemical engineering design
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Aug 18, 2026
Virus-like particles enable targeted gene engineering and pooled CRISPR screening in primary human myeloid cells.

|Dec 19, 2025
Virus-like particles enable targeted gene engineering and pooled CRISPR screening in primary human myeloid cells.

Hyuncheol Jung, Pascal Devant, Carter Ching

|Apr 26, 2024
Further Characterization of the Antiviral Transmembrane Protein MARCH8.

Takuya Tada, Yanzhao Zhang, Dechuan Kong

|Apr 24, 2024
Checkpoint inhibitor-expressing lentiviral vaccine suppresses tumor growth in preclinical cancer models.

Takuya Tada, Thomas D Norton, Rebecca Leibowitz

|May 30, 2023
Vectored immunoprophylaxis and treatment of SARS-CoV-2 infection in a preclinical model.

Takuya Tada, Julia Minnee, Nathaniel R Landau

|Jan 30, 2023
Vectored Immunoprophylaxis and Treatment of SARS-CoV-2 Infection.

Takuya Tada, Belinda M Dcosta, Julia Minnee

Pageof 3

Frequent Collaborators

9 joint publications

Nathaniel R Landau

8 joint publications

Belinda M Dcosta

3 joint publications

Yanzhao Zhang

3 joint publications

Hideaki Fujita